ReviewThe Lancet. Respiratory medicine2023
Home monitoring in interstitial lung diseases.
Review in The Lancet. Respiratory medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07673237 (Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease), which is not on this map. Cited by 56 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
Who cites it
56 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.
- Effects of Self-Management Interventions in People With Interstitial Lung Disease.Respiratory care · 2023Pooled it
- Trial
- Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: A Pulmonary Perspective on Recent Guidelines.Advances in therapy · 2026Review
- Expanding Remote Patient Monitoring for Pre-Lung Transplant Candidates With Interstitial Lung Disease.Clinical transplantation · 2026Article
- Patient Experiences of Digital Technology Use in Interstitial Lung Disease (PRODIGY-ILD Study): Qualitative Study Using Reflexive Thematic Analysis.JMIR human factors · 2026Observational
- Beyond Technological Access: Exploring Contextual Factors Related to Teleassessment Usability in Interstitial Lung Disease.International journal of environmental research and public health · 2026Article
- Exploring the Priorities for Home Self-Management Among Patients with Interstitial Lung Disease: A Mixed-Methods Approach Using Q-Methodology.Healthcare (Basel, Switzerland) · 2026Article
- Smartwatch-Derived SpORespirology case reports · 2026Article
- Holistic Management of Pulmonary Fibrosis: A Comprehensive Review.Medicina (Kaunas, Lithuania) · 2026Review
- Healthcare professionals' perspectives on implementation of home monitoring in individuals with pulmonary fibrosis.ERJ open research · 2026Article
- Deep Learning-Driven Early Diagnosis of Respiratory Diseases using CNN-RNN Fusion on Lung Sound Data.Scientific reports · 2025Article
- Defining Interstitial Lung Disease Education in Pulmonary Fellowship: A Mixed Methods Study.Chest · 2025Article
- Innovation in technologies for monitoring lung function in patients with respiratory disease.Breathe (Sheffield, England) · 2025Article
- Home is where spirometry should be: enhancing care for individuals with pulmonary fibrosis.ERJ open research · 2025Article
- Online home spirometry in national pulmonary fibrosis care: insights from daily practice.ERJ open research · 2025Article
- Caring for Rural Patients With Interstitial Lung Disease: Perspectives of Pulmonary Fibrosis Foundation Care Center Network Nurses and Providers.CHEST pulmonary · 2025Article
- Perception of the role of Telemedicine in Interstitial Lung Diseases: -Findings from Società Italiana di Pneumologia/ Italian Respiratory -Society (SIP-IRS) survey.Multidisciplinary respiratory medicine · 2025Article
- A Pragmatic Tele-Nursing Program Improves Satisfaction of Patients with Pulmonary Fibrosis and Their Caregivers-A Pilot Study.Medicina (Kaunas, Lithuania) · 2025Article
- Segmentation-Assisted Fusion-Based Classification for Automated CXR Image Analysis.Sensors (Basel, Switzerland) · 2025Article
- Innovating care for people with sarcoidosis using a machine learning-driven approach.Respiratory research · 2025Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
13 authors at 5 institutions in 5 countries.
Funding
Abstract
The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with interstitial lung diseases (ILDs). Home monitoring in ILD has the potential to improve access to specialist care, reduce the burden on health-care systems, improve quality of life for patients, identify acute and chronic disease worsening, guide treatment decisions, and simplify clinical trials. Home spirometry has been used in ILD for several years and studies with other devices (such as pulse oximeters, activity trackers, and cough monitors) have emerged. At the same time, challenges have surfaced, including technical, analytical, and implementational issues. In this Series paper, we provide an overview of experiences with home monitoring in ILD, address the challenges and limitations for both care and research, and provide future perspectives. VIDEO ABSTRACT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.